至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Pathogenic Abnormal Splicing Due to Intronic Deletions that Induce Biophysical Space Constraint for Spliceosome Assembly

Am J Hum Genet.. 2019; 
Bryen SJ1, Joshi H2, Evesson FJ3, Girard C4, Ghaoui R5, Waddell LB1, Testa AC6, Cummings B7, Arbuckle S8, Graf N8, Webster R9, MacArthur DG7, Laing NG6, Davis MR10, Lührmann R4, Cooper ST11.
Products/Services Used Details Operation
Gene Synthesis … promoter. PCR products were gel purified and used as template for in vitro<br> transcription reactions. WT-COL6A2 mut , Δ28-COL6A2 mut , AA-COL6A2 mut<br> constructs, inserted in Puc18, were synthesized by <b>GenScript</b> Inc. (USA) … Get A Quote

摘要

A precise genetic diagnosis is the single most important step for families with genetic disorders to enable personalized and preventative medicine. In addition to genetic variants in coding regions (exons) that can change a protein sequence, abnormal pre-mRNA splicing can be devastating for the encoded protein, inducing a frameshift or in-frame deletion/insertion of multiple residues. Non-coding variants that disrupt splicing are extremely challenging to identify. Stemming from an initial clinical discovery in two index Australian families, we define 25 families with genetic disorders caused by a class of pathogenic non-coding splice variant due to intronic deletions. These pathogenic intronic deletions spare a... More

关键词

5′ splice site; abnormal splicing; branchpoint; intronic deletion; non-coding variant; pathogenic splice variant; pre-mRNA splicing; spliceosome assembly